Erik Harris
CIK 1780113 · EVP & Chief Commercial Officer · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.71M
Companies
4
Total Filings
32
Lifetime Open-Market Net
-$2.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RARE | EVP & Chief Commercial Officer | 118,410 | $26.96 | $3.19M | -$2.66M | 25 | 2026-04-20 |
| RZLT | Director | 21,000 | $4.62 | $97.0K | $0 | 2 | 2025-11-21 |
| Inozyme Pharma, Inc. (INZY) Delisted | Director | — | $4.00 | — | $0 | 1 | 2024-10-07 |
| DNLI | Director | 17,052 | $24.69 | $421.0K | $0 | 3 | 2024-06-04 |
Recent Filings · Page 2 of 4
32 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-21 | RARE | Sell (S) | −305 | -$14.7K | EDGAR |
| 2023-06-05 | DNLI | Grant (A) | +4,216 | $0 | EDGAR |
| 2023-03-03 | RARE | Mixed | +20,999 | -$165.8K | EDGAR |
| 2022-06-22 | RARE | Sell (S) | −295 | -$16.2K | EDGAR |
| 2022-03-03 | RARE | Mixed | +11,287 | -$180.7K | EDGAR |
| 2022-02-07 | DNLI | Grant (A) | +6,869 | $0 | EDGAR |
| 2021-10-18 | RARE | Sell (S) | −303 | -$24.6K | EDGAR |
| 2021-07-08 | RARE | Sell (S) | −375 | -$34.3K | EDGAR |
| 2021-06-23 | RARE | Sell (S) | −1,009 | -$95.7K | EDGAR |
| 2021-05-10 | RARE | Sell (S) | −700 | -$79.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.